140 filings
8-K
MYMD
MyMD Pharmaceuticals Inc
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
8-K
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
MYMD
MyMD Pharmaceuticals Inc
18 Apr 24
Departure of Directors or Certain Officers
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
8-K/A
MYMD
MyMD Pharmaceuticals Inc
26 Mar 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
fsotw4p49o
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
l65s8or6f
5 Mar 24
Regulation FD Disclosure
11:00am
8-K
czw37g9qfuvbt
13 Feb 24
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
4:57pm
8-K
i1u8ww 2dtyhn0ma
6 Dec 23
Regulation FD Disclosure
9:15am
8-K
9np 8n5m52
19 Oct 23
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced
9:00am
8-K
emqgv6
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
k4b08ucw
4 Oct 23
MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023
4:30pm
8-K
t03kj46hacggzlofk 1y
8 Sep 23
Departure of Directors or Certain Officers
5:24pm
8-K
m33at
14 Aug 23
Regulation FD Disclosure
8:30am
8-K
z3a9m qys
3 Aug 23
MyMD Pharmaceuticals Phase 2 Trial Update
4:30pm
8-K
uygcv3p37g1i
1 Aug 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
q5skdzc46s2u6
31 Jul 23
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline
9:00am
8-K
0jhf5lreez3ge 3e
14 Jul 23
Other Events
8:30am
8-K
ypagivc
9 Jun 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:30pm
8-K
0zqsly
12 Apr 23
Regulation FD Disclosure
8:45am